Search Login Register

Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) Summary

Description: Congenital disorders, usually autosomal recessive, characterized by severe generalized lack of ADIPOSE TISSUE, extreme INSULIN RESISTANCE, and HYPERTRIGLYCERIDEMIA.

Also Known As: Berardinelli-Seip Congenital Lipodystrophy; Lipodystrophy, Congenital Generalized; Berardinelli-Seip Congenital Lipodystrophy, Type 1; Berardinelli-Seip Congenital Lipodystrophy, Type 2; Congenital Generalized Lipodystrophy Type 1 Show All >>

Networked: 90 relevant articles (1 outcomes, 4 trials/studies) for this Disease

Key Drugs and Agents for Congenital Generalized Lipodystrophy

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Fenfluramine : 1 outcome in 2 results : IBA
  2. Lipoatrophic diabetes : 1 outcome in 2 results : IBA
  3. Berardinelli-Seip congenital lipodystrophy type 2 : 1 study in 28 results : IBA
  4. Leptin : 1 study in 13 results : IBA
  5. Insulin (Novolin) : 1 study in 12 results : FDA 2
  6. Insulin-Like Growth Factor I (IGF-1) : 1 study in 2 results : IBA
  7. Blood Glucose (Blood Sugar) : 1 study in 1 result : IBA
  8. Spastic paraplegia 17 : 6 results : IBA
  9. Caveolin 1 : 5 results : IBA
  10. Lamin Type A (Lamin A) : 4 results : IBA
Show All >>

Diseases Related to Congenital Generalized Lipodystrophy

  1. Insulin Resistance
  2. Donohue Syndrome
  3. Lipodystrophy
  4. Diabetes Mellitus
  5. Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)
Show All >>

Key Therapies for Congenital Generalized Lipodystrophy

Efficacy Chart >>
  1. Kidney Transplantation : 1 result
  2. Total Parenteral Nutrition : 1 result
  3. Hypophysectomy : 1 result
  4. Drug Therapy (Chemotherapy) : 1 result
  5. Aftercare (After-Treatment) : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.